Th1, Th17, CXCL16 and homocysteine elevated after intracranial and cervical stent implantation.
The presence of Th1 and Th17 cells has been observed as major inducers in inflammation and immune responses associated stenting. However, there is rare data on the impact of Th1, Th17, CXCL16 and homocysteine after cerebral stent implantation. Here, we performed the statistical analysis to first evaluate the variation of the Th17and Th1 cells and their related cytokines, CXCL16 and homocysteine in the peripheral blood of patients with cerebral stenting. The flow cytometry was used to detect the proportion of Th1 and Th17 cells in peripheral blood mononuclear cells (PBMCs). The enzyme-linked immunosorbent assay was used to measure the serum concentrations of IFN-γ, IL-17 and CXCL16. Plasma homocysteine was examined by immunoturbidimetry. The level of Th1, CXCL16 and homocysteine showed an increase at 3 d, followed by the continuous decrease at 7 d and 3 months. The frequency of Th17 cells increased to a peak at three days, and subsequently decreased with a higher level than baseline. Our data revealed that the variation in Th1, Th17, CXCL16 and homocysteine in peripheral blood of patients with stenting may be implicated in inflammation after intracranial and cervical stent implantation. A better understanding of these factors will provide help for further drug design and clinical therapy.
a Department of Neurology , The First Affiliated Hospital, Guangxi Medical University , Nanning , China.
Yanyan
Y
Tang
a Department of Neurology , The First Affiliated Hospital, Guangxi Medical University , Nanning , China.
Yunfei
Y
Wei
a Department of Neurology , The First Affiliated Hospital, Guangxi Medical University , Nanning , China.
Ziming
Z
Ye
a Department of Neurology , The First Affiliated Hospital, Guangxi Medical University , Nanning , China.
Chao
C
Qin
D000368:Aged; D015415:Biomarkers / Q000097:blood; D002561:Cerebrovascular Disorders / Q000097:blood* / Q000601:surgery; D000075743:Chemokine CXCL16 / Q000097:blood*; D005260:Female; D005434:Flow Cytometry / Q000379:methods / Q000639:trends; D006710:Homocysteine / Q000097:blood*; D006801:Humans; D007963:Leukocytes, Mononuclear / Q000378:metabolism; D008297:Male; D008875:Middle Aged; D015607:Stents / Q000009:adverse effects* / Q000639:trends; D018417:Th1 Cells / Q000378:metabolism*; D058504:Th17 Cells / Q000378:metabolism*
D015415:Biomarkers; C423727:CXCL16 protein, human; D000075743:Chemokine CXCL16; D006710:Homocysteine
CXCL16; Homocysteine; Th1; Th17; inflammation; stenting